Information Library
Get to market faster - Managed Partnerships
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Grabbing a Leadership Position
March 26, 2009
Astellas-NovaQuest Alliance Establishes Market Leadership Platform for Vesicare -
Driving Near Term Sales & Savings
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, funded a dedicated sales force of 150 experienced Innovex cardiovascular representatives for two years, in return for a five-year royalty on the net sales of Advicor and its predecessor product, Niaspan®. PharmaBio also received warrants to purchase shares of Kos Pharmaceuticals stock. -
Harnessing a Speciality Salesforce
March 26, 2009
NovaQuest’s predecessor, PharmaBio Development, committed more than $400 million in milestone payments and sales force services to fund the launch of Cymbalta and support commercialization efforts for five years. A dedicated service company created by PharmaBio Development is providing more than 500 Innovex sales representatives to supplement the extensive Lilly primary care and specialty sales forces. -
Jumpstarting a Phase III Candidate
March 24, 2009
A global pharmaceutical company had a promising new formulation of a marketed product in early Phase III trials, but R&D budget pressures were likely to result in delays getting the product to market. -
Pace of Change
August 1, 2008
A Pharma TV interview with Ben Cons
Page 1 of 1 (5 items)